Goldman Sachs’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84.3M Buy
670,852
+66,155
+11% +$8.31M 0.01% 852
2025
Q1
$82.7M Sell
604,697
-165,623
-22% -$22.7M 0.01% 763
2024
Q4
$118M Sell
770,320
-218,721
-22% -$33.4M 0.02% 605
2024
Q3
$192M Sell
989,041
-431,819
-30% -$83.7M 0.03% 460
2024
Q2
$329M Buy
1,420,860
+426,495
+43% +$98.9M 0.06% 305
2024
Q1
$214M Sell
994,365
-101,458
-9% -$21.9M 0.04% 411
2023
Q4
$284M Buy
1,095,823
+304,978
+39% +$78.9M 0.05% 326
2023
Q3
$203M Sell
790,845
-34,820
-4% -$8.95M 0.04% 373
2023
Q2
$235M Buy
825,665
+164,216
+25% +$46.8M 0.05% 315
2023
Q1
$184M Sell
661,449
-317,433
-32% -$88.3M 0.04% 392
2022
Q4
$271M Sell
978,882
-418,762
-30% -$116M 0.07% 273
2022
Q3
$373M Sell
1,397,644
-246,405
-15% -$65.8M 0.09% 167
2022
Q2
$335M Buy
1,644,049
+333,945
+25% +$68.1M 0.08% 188
2022
Q1
$276M Buy
1,310,104
+360,864
+38% +$76M 0.06% 287
2021
Q4
$228M Buy
949,240
+149,312
+19% +$35.8M 0.05% 349
2021
Q3
$226M Sell
799,928
-41,150
-5% -$11.6M 0.05% 334
2021
Q2
$291M Buy
841,078
+3,518
+0.4% +$1.22M 0.07% 248
2021
Q1
$234M Buy
837,560
+289,432
+53% +$81M 0.06% 284
2020
Q4
$134M Sell
548,128
-338,247
-38% -$82.8M 0.03% 410
2020
Q3
$251M Sell
886,375
-451,256
-34% -$128M 0.07% 224
2020
Q2
$358M Buy
1,337,631
+61,867
+5% +$16.6M 0.11% 158
2020
Q1
$404M Sell
1,275,764
-495,863
-28% -$157M 0.14% 119
2019
Q4
$526M Sell
1,771,627
-19,182
-1% -$5.69M 0.13% 123
2019
Q3
$417M Buy
1,790,809
+606
+0% +$141K 0.12% 142
2019
Q2
$419M Buy
1,790,203
+124,721
+7% +$29.2M 0.12% 144
2019
Q1
$394M Sell
1,665,482
-135,739
-8% -$32.1M 0.12% 135
2018
Q4
$542M Sell
1,801,221
-462,032
-20% -$139M 0.17% 80
2018
Q3
$800M Sell
2,263,253
-10,049
-0.4% -$3.55M 0.21% 69
2018
Q2
$660M Sell
2,273,302
-175,551
-7% -$51M 0.18% 83
2018
Q1
$671M Buy
2,448,853
+153,551
+7% +$42M 0.17% 91
2017
Q4
$731M Buy
2,295,302
+178,534
+8% +$56.9M 0.17% 81
2017
Q3
$663M Buy
2,116,768
+383,275
+22% +$120M 0.16% 78
2017
Q2
$470M Sell
1,733,493
-5,349
-0.3% -$1.45M 0.12% 120
2017
Q1
$475M Buy
1,738,842
+440,777
+34% +$121M 0.13% 111
2016
Q4
$368M Buy
1,298,065
+140,732
+12% +$39.9M 0.1% 135
2016
Q3
$362M Buy
1,157,333
+25,338
+2% +$7.93M 0.11% 135
2016
Q2
$274M Sell
1,131,995
-306,114
-21% -$74M 0.09% 184
2016
Q1
$374M Sell
1,438,109
-102,964
-7% -$26.8M 0.12% 117
2015
Q4
$472M Sell
1,541,073
-157,376
-9% -$48.2M 0.15% 99
2015
Q3
$496M Buy
1,698,449
+264,751
+18% +$77.3M 0.17% 79
2015
Q2
$579M Buy
1,433,698
+169,213
+13% +$68.4M 0.18% 78
2015
Q1
$534M Sell
1,264,485
-538,044
-30% -$227M 0.17% 87
2014
Q4
$612M Buy
1,802,529
+609,082
+51% +$207M 0.19% 67
2014
Q3
$395M Sell
1,193,447
-205,027
-15% -$67.8M 0.13% 107
2014
Q2
$441M Buy
1,398,474
+161,425
+13% +$50.9M 0.14% 110
2014
Q1
$378M Buy
1,237,049
+89,023
+8% +$27.2M 0.12% 126
2013
Q4
$321M Buy
1,148,026
+262,589
+30% +$73.4M 0.11% 153
2013
Q3
$213M Sell
885,437
-158,607
-15% -$38.2M 0.08% 201
2013
Q2
$225M Buy
+1,044,044
New +$225M 0.09% 176